Unknown

Dataset Information

0

Successful ruxolitinib administration for a patient with steroid-refractory idiopathic pneumonia syndrome following hematopoietic stem cell transplantation: A case report and literature review.


ABSTRACT: Idiopathic pneumonia syndrome (IPS) is an acute lung complication observed after the early posthematopoietic stem cell transplantation (HSCT) period. Ruxolitinib was effective for a patient with myelodysplastic syndrome who developed severe IPS after second HSCT. No severe adverse effects were observed. Ruxolitinib may be an alternative choice for HSCT-related IPS.

SUBMITTER: Tomomasa D 

PROVIDER: S-EPMC8693824 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC7841467 | biostudies-literature
| S-EPMC7812291 | biostudies-literature
| S-EPMC8055912 | biostudies-literature
| S-EPMC5902640 | biostudies-literature
| S-EPMC4977623 | biostudies-literature
| S-EPMC7654848 | biostudies-literature
| S-EPMC7035790 | biostudies-literature
| S-EPMC7011641 | biostudies-literature
| S-EPMC8571747 | biostudies-literature
| S-EPMC3186343 | biostudies-literature